Award Clause Example with 4 Variations from Business Contracts

This page contains Award clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Award. On December 30, 2015 ("Grant Date"), the Company granted to the Participant an option ("Option") to purchase up to 6,000,000 shares of the Company's common stock, par value $0.0001 per share ("Share" or "Shares"), subject to the terms and conditions of this Agreement. The purchase price per Share ("Exercise Price") is $0.063, which represents the fair market value of each Share on the Grant Date. This grant is in satisfaction of the Company's obligation to the Participant with respect to the New... Option Award provided for in the Executive Compensation Agreement by and between the Company and the Participant entered into as of March 10, 2015, effective as of January 1, 2015, as amended by Amendment No. 1 to Executive Compensation Agreement dated December 30, 2015 ("Executive Compensation Agreement"). View More Arrow
Found in PharmaCyte Biotech, Inc. contract

Variations of a "Award" Clause from Business Contracts

Award. On December 30, 2015 ("Grant Date"), the The Company has granted to the Participant an option ("Option") to purchase up to 6,000,000 2,400,000 shares of the Company's common stock, stock annually, par value $0.0001 per share ("Share" or "Shares"), subject to the terms and conditions of this Agreement. The purchase price per Share ("Exercise Price") is $0.063, $0.11, which represents the fair market value of each Share the shares on the Grant Date. date of the grant. This grant is in satisfaction... of the Company's obligation to the Participant with respect to the New Additional Option Award Awards provided for in the Executive Compensation Agreement by and between the Company and the Participant entered into as of March 10, 2015, effective as of January 1, 2015, as amended by Amendment No. 1 to Executive Compensation Agreement dated December 30, 2015 ("Executive Compensation ("Compensation Agreement"). View More Arrow
Found in PharmaCyte Biotech, Inc. contract
Award. On December 30, 2015 ("Grant Date"), the The Company has granted to the Participant an option ("Option") to purchase up to 6,000,000 10,000,000 shares of the Company's common stock, par value $0.0001 per share ("Share" or "Shares"), subject to the terms and conditions of this Agreement. The purchase price per Share ("Exercise Price") is $0.063, $0.11, which represents the fair market value of each Share the shares on the Grant Date. date of the grant. This grant is in satisfaction of the Company...'s obligation to the Participant with respect to the New Option Award provided for in pursuant to the Executive Compensation Agreement by and between the Company and the Participant entered into as of March 10, 2015, effective as of January 1, 2015, as amended by Amendment No. 1 to Executive Compensation Agreement dated December 30, 2015 ("Executive Compensation ("Compensation Agreement"). View More Arrow
Found in PharmaCyte Biotech, Inc. contract
Award. On December 30, 2015 ("Grant Date"), the The Company has granted to the Participant an option ("Option") to purchase up to 6,000,000 10,000,000 shares of the Company's common stock, par value $0.0001 per share ("Share" or "Shares"), subject to the terms and conditions of this Agreement. The purchase price per Share ("Exercise Price") is $0.063, $0.11, which represents the fair market value of each Share the shares on the Grant Date. date of the grant. This grant is in satisfaction of the Company...'s obligation to the Participant with respect to the New Option Award provided for in pursuant to the Executive Compensation Agreement by and between the Company and the Participant entered into as of March 10, 2015, effective as of January 1, 2015, as amended by Amendment No. 1 to Executive Compensation Agreement dated December 30, 2015 ("Executive Compensation ("Compensation Agreement"). View More Arrow
Found in PharmaCyte Biotech, Inc. contract
Award. On December 30, 2015 March 9, 2017 ("Grant Date"), the Company granted to the Participant an option ("Option") to purchase up to 6,000,000 1,500,000 shares of the Company's common stock, stock ("Common Stock"), par value $0.0001 per share ("Share" or "Shares"), subject to the terms and conditions of this Agreement. The purchase price per Share ("Exercise Price") is $0.063, $0.1040, which represents the fair market value of each Share on the Grant Date. This grant is in satisfaction of the Compan...y's obligation to the Participant with respect to the New Fourth Option Award provided for in the Executive Compensation Agreement by and between the Company and the Participant entered into as of March 10, 2015, effective as of January 1, 2015, as amended by Amendment No. 1 to Executive Compensation Agreement dated December 30, 2015 and by Amendment No. 2 to Executive Compensation Agreement dated March 10, 2017 ("Executive Compensation Agreement"). View More Arrow
Found in PharmaCyte Biotech, Inc. contract